MedPath

Mylan Institutional LLC

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

105

FDA:105

Drug Approvals

Dexamethasone Sodium Phosphate

Approval Date
Mar 5, 2024
FDA

Docetaxel

Approval Date
Feb 21, 2024
FDA

Rifampin

Approval Date
Jan 5, 2024
FDA

Ultiva

Approval Date
Dec 20, 2023
FDA

ROPIVACAINE HYDROCHLORIDE

Approval Date
Dec 15, 2023
FDA

Methadone Hydrochloride

Approval Date
Dec 1, 2023
FDA

linezolid

Approval Date
Nov 15, 2023
FDA

Levetiracetam

Approval Date
Oct 15, 2023
FDA

Esmolol Hydrochloride

Approval Date
Sep 15, 2023
FDA

Docetaxel

Approval Date
Sep 5, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy